These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8394239)

  • 1. Long-term experience with sumatriptan in the treatment of migraine.
    Tansey MJ; Pilgrim AJ; Martin PM
    Eur Neurol; 1993; 33(4):310-5. PubMed ID: 8394239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sumatriptan in the treatment of acute migraine attacks].
    Diener HC
    Internist (Berl); 1993 Jan; 34(1):63-6; discussion 66. PubMed ID: 8382666
    [No Abstract]   [Full Text] [Related]  

  • 3. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW
    Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.
    Bomhof MA; Heywood J; Pradalier A; Enahoro H; Winter P; Hassani H
    Cephalalgia; 1998 Jan; 18(1):33-7. PubMed ID: 9601622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
    Ensink FB
    J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
    Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG; D'Allens H; Richard A
    J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sumatriptan--future development, alternative features and potential new indications].
    Arnold WS
    Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
    Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.